ERCC6_HUMAN - dbPTM
ERCC6_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ERCC6_HUMAN
UniProt AC Q03468
Protein Name DNA excision repair protein ERCC-6
Gene Name ERCC6
Organism Homo sapiens (Human).
Sequence Length 1493
Subcellular Localization Nucleus .
Protein Description Essential factor involved in transcription-coupled nucleotide excision repair which allows RNA polymerase II-blocking lesions to be rapidly removed from the transcribed strand of active genes. Upon DNA-binding, it locally modifies DNA conformation by wrapping the DNA around itself, thereby modifying the interface between stalled RNA polymerase II and DNA. It is required for transcription-coupled repair complex formation. It recruits the CSA complex (DCX(ERCC8) complex), nucleotide excision repair proteins and EP300 to the at sites of RNA polymerase II-blocking lesions..
Protein Sequence MPNEGIPHSSQTQEQDCLQSQPVSNNEEMAIKQESGGDGEVEEYLSFRSVGDGLSTSAVGCASAAPRRGPALLHIDRHQIQAVEPSAQALELQGLGVDVYDQDVLEQGVLQQVDNAIHEASRASQLVDVEKEYRSVLDDLTSCTTSLRQINKIIEQLSPQAATSRDINRKLDSVKRQKYNKEQQLKKITAKQKHLQAILGGAEVKIELDHASLEEDAEPGPSSLGSMLMPVQETAWEELIRTGQMTPFGTQIPQKQEKKPRKIMLNEASGFEKYLADQAKLSFERKKQGCNKRAARKAPAPVTPPAPVQNKNKPNKKARVLSKKEERLKKHIKKLQKRALQFQGKVGLPKARRPWESDMRPEAEGDSEGEESEYFPTEEEEEEEDDEVEGAEADLSGDGTDYELKPLPKGGKRQKKVPVQEIDDDFFPSSGEEAEAASVGEGGGGGRKVGRYRDDGDEDYYKQRLRRWNKLRLQDKEKRLKLEDDSEESDAEFDEGFKVPGFLFKKLFKYQQTGVRWLWELHCQQAGGILGDEMGLGKTIQIIAFLAGLSYSKIRTRGSNYRFEGLGPTVIVCPTTVMHQWVKEFHTWWPPFRVAILHETGSYTHKKEKLIRDVAHCHGILITSYSYIRLMQDDISRYDWHYVILDEGHKIRNPNAAVTLACKQFRTPHRIILSGSPMQNNLRELWSLFDFIFPGKLGTLPVFMEQFSVPITMGGYSNASPVQVKTAYKCACVLRDTINPYLLRRMKSDVKMSLSLPDKNEQVLFCRLTDEQHKVYQNFVDSKEVYRILNGEMQIFSGLIALRKICNHPDLFSGGPKNLKGLPDDELEEDQFGYWKRSGKMIVVESLLKIWHKQGQRVLLFSQSRQMLDILEVFLRAQKYTYLKMDGTTTIASRQPLITRYNEDTSIFVFLLTTRVGGLGVNLTGANRVVIYDPDWNPSTDTQARERAWRIGQKKQVTVYRLLTAGTIEEKIYHRQIFKQFLTNRVLKDPKQRRFFKSNDLYELFTLTSPDASQSTETSAIFAGTGSDVQTPKCHLKRRIQPAFGADHDVPKRKKFPASNISVNDATSSEEKSEAKGAEVNAVTSNRSDPLKDDPHMSSNVTSNDRLGEETNAVSGPEELSVISGNGECSNSSGTGKTSMPSGDESIDEKLGLSYKRERPSQAQTEAFWENKQMENNFYKHKSKTKHHSVAEEETLEKHLRPKQKPKNSKHCRDAKFEGTRIPHLVKKRRYQKQDSENKSEAKEQSNDDYVLEKLFKKSVGVHSVMKHDAIMDGASPDYVLVEAEANRVAQDALKALRLSRQRCLGAVSGVPTWTGHRGISGAPAGKKSRFGKKRNSNFSVQHPSSTSPTEKCQDGIMKKEGKDNVPEHFSGRAEDADSSSGPLASSSLLAKMRARNHLILPERLESESGHLQEASALLPTTEHDDLLVEMRNFIAFQAHTDGQASTREILQEFESKLSASQSCVFRELLRNLCTFHRTSGGEGIWKLKPEYC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
9PhosphorylationPNEGIPHSSQTQEQD
CCCCCCCCCCCCCHH
20.8423663014
10PhosphorylationNEGIPHSSQTQEQDC
CCCCCCCCCCCCHHH
33.9223663014
12PhosphorylationGIPHSSQTQEQDCLQ
CCCCCCCCCCHHHHH
35.7023663014
20PhosphorylationQEQDCLQSQPVSNNE
CCHHHHHCCCCCCCH
24.4123663014
32SumoylationNNEEMAIKQESGGDG
CCHHEEEEECCCCCC
38.17-
35PhosphorylationEMAIKQESGGDGEVE
HEEEEECCCCCCCHH
45.6528985074
44PhosphorylationGDGEVEEYLSFRSVG
CCCCHHEEEEEEECC
8.3027642862
46PhosphorylationGEVEEYLSFRSVGDG
CCHHEEEEEEECCCC
20.0828102081
55PhosphorylationRSVGDGLSTSAVGCA
EECCCCCCCCCCCCC
26.3322210691
57PhosphorylationVGDGLSTSAVGCASA
CCCCCCCCCCCCCCC
19.9928555341
124PhosphorylationIHEASRASQLVDVEK
HHHHHHHHHHCCHHH
23.9620068231
124PhosphorylationIHEASRASQLVDVEK
HHHHHHHHHHCCHHH
23.9620068231
131UbiquitinationSQLVDVEKEYRSVLD
HHHCCHHHHHHHHHH
60.95-
158PhosphorylationNKIIEQLSPQAATSR
HHHHHHHCHHHHHHH
18.0516964243
158PhosphorylationNKIIEQLSPQAATSR
HHHHHHHCHHHHHHH
18.0529255136
163PhosphorylationQLSPQAATSRDINRK
HHCHHHHHHHHHHHH
27.5823663014
164PhosphorylationLSPQAATSRDINRKL
HCHHHHHHHHHHHHH
24.1923663014
170MethylationTSRDINRKLDSVKRQ
HHHHHHHHHHHHHHH
52.7518438403
173PhosphorylationDINRKLDSVKRQKYN
HHHHHHHHHHHHHCC
39.72-
173PhosphorylationDINRKLDSVKRQKYN
HHHHHHHHHHHHHCC
39.7222673903
212PhosphorylationKIELDHASLEEDAEP
EEEECCCCHHCCCCC
32.66-
242PhosphorylationAWEELIRTGQMTPFG
HHHHHHHHCCCCCCC
25.44-
242PhosphorylationAWEELIRTGQMTPFG
HHHHHHHHCCCCCCC
25.44-
246PhosphorylationLIRTGQMTPFGTQIP
HHHHCCCCCCCCCCC
13.9525627689
246PhosphorylationLIRTGQMTPFGTQIP
HHHHCCCCCCCCCCC
13.9521815630
250PhosphorylationGQMTPFGTQIPQKQE
CCCCCCCCCCCCCCC
24.57-
250PhosphorylationGQMTPFGTQIPQKQE
CCCCCCCCCCCCCCC
24.57-
255AcetylationFGTQIPQKQEKKPRK
CCCCCCCCCCCCCCE
55.8826051181
255SumoylationFGTQIPQKQEKKPRK
CCCCCCCCCCCCCCE
55.8828112733
262SumoylationKQEKKPRKIMLNEAS
CCCCCCCEEEECCCC
40.78-
262SumoylationKQEKKPRKIMLNEAS
CCCCCCCEEEECCCC
40.78-
297MethylationCNKRAARKAPAPVTP
CCHHHHHCCCCCCCC
54.7318438403
303PhosphorylationRKAPAPVTPPAPVQN
HCCCCCCCCCCCCCC
23.6125627689
303PhosphorylationRKAPAPVTPPAPVQN
HCCCCCCCCCCCCCC
23.6130266825
345UbiquitinationRALQFQGKVGLPKAR
HHHHHCCCCCCCCCC
23.50-
429PhosphorylationIDDDFFPSSGEEAEA
CCCCCCCCCCHHHHH
45.9018669648
429PhosphorylationIDDDFFPSSGEEAEA
CCCCCCCCCCHHHHH
45.9025159151
430PhosphorylationDDDFFPSSGEEAEAA
CCCCCCCCCHHHHHH
50.9218669648
430PhosphorylationDDDFFPSSGEEAEAA
CCCCCCCCCHHHHHH
50.9223927012
438PhosphorylationGEEAEAASVGEGGGG
CHHHHHHCCCCCCCC
37.3917081983
438PhosphorylationGEEAEAASVGEGGGG
CHHHHHHCCCCCCCC
37.3923927012
448MethylationEGGGGGRKVGRYRDD
CCCCCCCCCCCCCCC
52.9318438403
486PhosphorylationRLKLEDDSEESDAEF
CCCCCCCCHHCHHCC
56.4322167270
489PhosphorylationLEDDSEESDAEFDEG
CCCCCHHCHHCCCCC
37.7622167270
554PhosphorylationAGLSYSKIRTRGSNY
HCCCHHHHHCCCCCC
4.4625850435
554PhosphorylationAGLSYSKIRTRGSNY
HCCCHHHHHCCCCCC
4.4625850435
556PhosphorylationLSYSKIRTRGSNYRF
CCHHHHHCCCCCCCC
42.7424719451
560PhosphorylationKIRTRGSNYRFEGLG
HHHCCCCCCCCCCCC
34.5223090842
560PhosphorylationKIRTRGSNYRFEGLG
HHHCCCCCCCCCCCC
34.5223090842
561PhosphorylationIRTRGSNYRFEGLGP
HHCCCCCCCCCCCCC
20.5523090842
561PhosphorylationIRTRGSNYRFEGLGP
HHCCCCCCCCCCCCC
20.5523090842
576PhosphorylationTVIVCPTTVMHQWVK
EEEEECHHHHHHHHH
10.8524719451
623PhosphorylationHCHGILITSYSYIRL
HHCCEEEECHHHHHH
20.4020860994
624PhosphorylationCHGILITSYSYIRLM
HCCEEEECHHHHHHH
12.70-
625PhosphorylationHGILITSYSYIRLMQ
CCEEEECHHHHHHHH
9.24-
626PhosphorylationGILITSYSYIRLMQD
CEEEECHHHHHHHHC
17.5320860994
663UbiquitinationAAVTLACKQFRTPHR
HHHHHHHHHCCCCCE
47.03-
729UbiquitinationVQVKTAYKCACVLRD
CCCHHHHHHHHHHHH
16.94-
748PhosphorylationYLLRRMKSDVKMSLS
HHHHHHHCCCEEEEE
37.9929759185
755PhosphorylationSDVKMSLSLPDKNEQ
CCCEEEEECCCCCCE
30.4629759185
759UbiquitinationMSLSLPDKNEQVLFC
EEEECCCCCCEEEEE
61.52-
774UbiquitinationRLTDEQHKVYQNFVD
EECHHHHHHHHHCCC
42.19-
776PhosphorylationTDEQHKVYQNFVDSK
CHHHHHHHHHCCCHH
11.5326270265
782PhosphorylationVYQNFVDSKEVYRIL
HHHHCCCHHHHHHHH
25.9726270265
783UbiquitinationYQNFVDSKEVYRILN
HHHCCCHHHHHHHHC
46.89-
817UbiquitinationDLFSGGPKNLKGLPD
HHHCCCCCCCCCCCC
77.51-
820UbiquitinationSGGPKNLKGLPDDEL
CCCCCCCCCCCCCCC
68.73-
836UbiquitinationEDQFGYWKRSGKMIV
CCCCCCHHHCCCEEE
28.36-
846PhosphorylationGKMIVVESLLKIWHK
CCEEEEEHHHHHHHH
27.6524719451
862PhosphorylationGQRVLLFSQSRQMLD
CCEEEEEECHHHHHH
27.5022468782
864PhosphorylationRVLLFSQSRQMLDIL
EEEEEECHHHHHHHH
24.2322468782
888PhosphorylationTYLKMDGTTTIASRQ
EEEEECCCEEEEECC
19.2628450419
889PhosphorylationYLKMDGTTTIASRQP
EEEECCCEEEEECCC
23.0228450419
890PhosphorylationLKMDGTTTIASRQPL
EEECCCEEEEECCCE
17.8728450419
893PhosphorylationDGTTTIASRQPLITR
CCCEEEEECCCEEEE
27.8328450419
932PhosphorylationGANRVVIYDPDWNPS
CCCEEEEECCCCCCC
15.1522817900
955UbiquitinationAWRIGQKKQVTVYRL
HHHHCCCCEEEEEEE
41.96-
1009PhosphorylationYELFTLTSPDASQST
HHEEEECCCCCCCCC
24.7218669648
1054MethylationDHDVPKRKKFPASNI
CCCCCCCCCCCCCCC
65.9618438403
1062PhosphorylationKFPASNISVNDATSS
CCCCCCCCCCCCCCH
21.0828555341
1067PhosphorylationNISVNDATSSEEKSE
CCCCCCCCCHHHHHH
35.3328450419
1068PhosphorylationISVNDATSSEEKSEA
CCCCCCCCHHHHHHH
37.1621815630
1069PhosphorylationSVNDATSSEEKSEAK
CCCCCCCHHHHHHHC
45.4828450419
1084PhosphorylationGAEVNAVTSNRSDPL
CCCCEEEECCCCCCC
20.2023312004
1085PhosphorylationAEVNAVTSNRSDPLK
CCCEEEECCCCCCCC
24.5223312004
1088PhosphorylationNAVTSNRSDPLKDDP
EEEECCCCCCCCCCC
48.0723312004
1102PhosphorylationPHMSSNVTSNDRLGE
CCCCCCCCCCCCCCC
26.5122210691
1111PhosphorylationNDRLGEETNAVSGPE
CCCCCCCCCCCCCCC
24.9522210691
1115PhosphorylationGEETNAVSGPEELSV
CCCCCCCCCCCCCEE
46.3430175587
1133PhosphorylationNGECSNSSGTGKTSM
CCCCCCCCCCCCCCC
44.6222210691
1138PhosphorylationNSSGTGKTSMPSGDE
CCCCCCCCCCCCCCC
31.4422199227
1139PhosphorylationSSGTGKTSMPSGDES
CCCCCCCCCCCCCCC
31.9822199227
1142PhosphorylationTGKTSMPSGDESIDE
CCCCCCCCCCCCHHH
50.6825159151
1146PhosphorylationSMPSGDESIDEKLGL
CCCCCCCCHHHHHCC
39.8325159151
1156UbiquitinationEKLGLSYKRERPSQA
HHHCCCCCCCCCCHH
44.39-
1189PhosphorylationKSKTKHHSVAEEETL
CCCCCCCCCCCHHHH
23.8129978859
1195PhosphorylationHSVAEEETLEKHLRP
CCCCCHHHHHHHCCC
43.4230631047
1198UbiquitinationAEEETLEKHLRPKQK
CCHHHHHHHCCCCCC
51.56-
1216AcetylationSKHCRDAKFEGTRIP
CCCCCCCCCCCCCHH
48.5126051181
1254UbiquitinationNDDYVLEKLFKKSVG
CHHHHHHHHHHHCCC
55.87-
1258UbiquitinationVLEKLFKKSVGVHSV
HHHHHHHHCCCCCHH
42.93-
1276PhosphorylationDAIMDGASPDYVLVE
HHHCCCCCCCEEEEE
24.6725159151
1279PhosphorylationMDGASPDYVLVEAEA
CCCCCCCEEEEEHHH
10.0821712546
1295UbiquitinationRVAQDALKALRLSRQ
HHHHHHHHHHHHHHH
47.28-
1337PhosphorylationRFGKKRNSNFSVQHP
CCCCCCCCCCCCCCC
43.2025159151
1340PhosphorylationKKRNSNFSVQHPSST
CCCCCCCCCCCCCCC
25.7225159151
1345PhosphorylationNFSVQHPSSTSPTEK
CCCCCCCCCCCCCHH
44.0923401153
1346PhosphorylationFSVQHPSSTSPTEKC
CCCCCCCCCCCCHHH
37.0422167270
1347PhosphorylationSVQHPSSTSPTEKCQ
CCCCCCCCCCCHHHC
42.9622167270
1348PhosphorylationVQHPSSTSPTEKCQD
CCCCCCCCCCHHHCC
31.6022167270
1350PhosphorylationHPSSTSPTEKCQDGI
CCCCCCCCHHHCCCH
48.0922167270
1352UbiquitinationSSTSPTEKCQDGIMK
CCCCCCHHHCCCHHH
39.41-
1359UbiquitinationKCQDGIMKKEGKDNV
HHCCCHHHCCCCCCC
45.83-
1363UbiquitinationGIMKKEGKDNVPEHF
CHHHCCCCCCCCCHH
47.42-
1379PhosphorylationGRAEDADSSSGPLAS
CCCCCCCCCCCCCCC
28.2930576142
1380PhosphorylationRAEDADSSSGPLASS
CCCCCCCCCCCCCCH
39.6020873877
1381PhosphorylationAEDADSSSGPLASSS
CCCCCCCCCCCCCHH
48.6720873877
1388PhosphorylationSGPLASSSLLAKMRA
CCCCCCHHHHHHHHH
25.5525627689
1392UbiquitinationASSSLLAKMRARNHL
CCHHHHHHHHHHCCC
28.96-
1457UbiquitinationILQEFESKLSASQSC
HHHHHHHHCCHHHHH
38.9821890473
1461PhosphorylationFESKLSASQSCVFRE
HHHHCCHHHHHHHHH
21.1717525332
1487UbiquitinationSGGEGIWKLKPEYC-
CCCCCCEECCCCCC-
44.72-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
10SPhosphorylationKinaseATMQ13315
Uniprot
158SPhosphorylationKinaseCDK2P24941
Uniprot
932YPhosphorylationKinaseABL1P00519
GPS
-KUbiquitinationE3 ubiquitin ligaseERCC8Q13216
PMID:16751180

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
10SPhosphorylation

29203878
158SPhosphorylation

16964243
205KSumoylation

26620705

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ERCC6_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
XPA_HUMANXPAphysical
8999876
H2B1B_HUMANHIST1H2BBphysical
11003660
H31_HUMANHIST1H3Aphysical
11003660
RPA1_HUMANPOLR1Aphysical
20541997
XPA_HUMANXPAphysical
20541997
ERCC2_HUMANERCC2physical
20541997
XPF_HUMANERCC4physical
20541997
RPB1_HUMANPOLR2Aphysical
20541997
ERCC8_HUMANERCC8physical
20541997
DDB1_HUMANDDB1physical
20541997
HMGN1_HUMANHMGN1physical
20541997
PCNA_HUMANPCNAphysical
20541997
DPOD1_HUMANPOLD1physical
20541997
H2A2C_HUMANHIST2H2ACphysical
20541997
RPB1_HUMANPOLR2Aphysical
16916636
ERCC8_HUMANERCC8physical
16916636
ERCC3_HUMANERCC3physical
16916636
ERCC5_HUMANERCC5physical
16916636
RFA1_HUMANRPA1physical
16916636
BRCA1_HUMANBRCA1physical
21756275
ERCC8_HUMANERCC8physical
7664335
P53_HUMANTP53physical
22032989
ERCC8_HUMANERCC8physical
22032989
MDM2_HUMANMDM2physical
22032989
DDB1_HUMANDDB1physical
22032989
CUL4A_HUMANCUL4Aphysical
22032989
CUL4B_HUMANCUL4Bphysical
22032989
CAND1_HUMANCAND1physical
22032989
UBP7_HUMANUSP7physical
22032989
CSN3_HUMANCOPS3physical
22032989
CSN4_HUMANCOPS4physical
22032989
CSN6_HUMANCOPS6physical
22032989
CUL7_HUMANCUL7physical
22032989
OGG1_HUMANOGG1physical
20100872
SSBP_HUMANSSBP1physical
20100872
PARP1_HUMANPARP1physical
16107709
RPA1_HUMANPOLR1Aphysical
23667505
KAT2B_HUMANKAT2Bphysical
23667505
UBC_HUMANUBCphysical
20541997
SPTA1_HUMANSPTA1physical
16889989

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
133540Cockayne syndrome B (CSB)
214150Cerebro-oculo-facio-skeletal syndrome 1 (COFS1)
278800De Sanctis-Cacchione syndrome (DSC)
613761Macular degeneration, age-related, 5 (ARMD5)
600630UV-sensitive syndrome 1 (UVSS1)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ERCC6_HUMAN

loading...

Related Literatures of Post-Translational Modification
Methylation
ReferencePubMed
"Protein lysine methyltransferase G9a acts on non-histone targets.";
Rathert P., Dhayalan A., Murakami M., Zhang X., Tamas R.,Jurkowska R., Komatsu Y., Shinkai Y., Cheng X., Jeltsch A.;
Nat. Chem. Biol. 4:344-346(2008).
Cited for: METHYLATION AT LYS-170; LYS-297; LYS-448 AND LYS-1054.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1142, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158; SER-429; SER-430;SER-486; SER-489; SER-1142 AND SER-1348, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1461, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-486, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158, AND MASSSPECTROMETRY.

TOP